347 related articles for article (PubMed ID: 26452709)
1. Erythropoietin in traumatic brain injury (EPO-TBI): a double-blind randomised controlled trial.
Nichol A; French C; Little L; Haddad S; Presneill J; Arabi Y; Bailey M; Cooper DJ; Duranteau J; Huet O; Mak A; McArthur C; Pettilä V; Skrifvars M; Vallance S; Varma D; Wills J; Bellomo R; ;
Lancet; 2015 Dec; 386(10012):2499-506. PubMed ID: 26452709
[TBL] [Abstract][Full Text] [Related]
2. Statistical analysis plan for the Erythropoietin in Traumatic Brain Injury trial: a randomised controlled trial of erythropoietin versus placebo in moderate and severe traumatic brain injury.
Presneill J; Little L; Nichol A; French C; Cooper DJ; Haddad S; Duranteau J; Huet O; Skrifvars M; Arabi Y; Bellomo R; ;
Trials; 2014 Dec; 15():501. PubMed ID: 25528574
[TBL] [Abstract][Full Text] [Related]
3. Erythropoietin in traumatic brain injury: study protocol for a randomised controlled trial.
Nichol A; French C; Little L; Presneill J; Cooper DJ; Haddad S; Duranteau J; Huet O; Skrifvars M; Arabi Y; Bellomo R;
Trials; 2015 Feb; 16():39. PubMed ID: 25884605
[TBL] [Abstract][Full Text] [Related]
4. Hydrocortisone and fludrocortisone for prevention of hospital-acquired pneumonia in patients with severe traumatic brain injury (Corti-TC): a double-blind, multicentre phase 3, randomised placebo-controlled trial.
Asehnoune K; Seguin P; Allary J; Feuillet F; Lasocki S; Cook F; Floch H; Chabanne R; Geeraerts T; Roger C; Perrigault PF; Hanouz JL; Lukaszewicz AC; Biais M; Boucheix P; Dahyot-Fizelier C; Capdevila X; Mahe PJ; Le Maguet P; Paugam-Burtz C; Gergaud S; Plaud B; Constantin JM; Malledant Y; Flet L; Sebille V; Roquilly A;
Lancet Respir Med; 2014 Sep; 2(9):706-16. PubMed ID: 25066331
[TBL] [Abstract][Full Text] [Related]
5. Safety and efficacy of abobotulinumtoxinA for hemiparesis in adults with upper limb spasticity after stroke or traumatic brain injury: a double-blind randomised controlled trial.
Gracies JM; Brashear A; Jech R; McAllister P; Banach M; Valkovic P; Walker H; Marciniak C; Deltombe T; Skoromets A; Khatkova S; Edgley S; Gul F; Catus F; De Fer BB; Vilain C; Picaut P;
Lancet Neurol; 2015 Oct; 14(10):992-1001. PubMed ID: 26318836
[TBL] [Abstract][Full Text] [Related]
6. Combination of everolimus with trastuzumab plus paclitaxel as first-line treatment for patients with HER2-positive advanced breast cancer (BOLERO-1): a phase 3, randomised, double-blind, multicentre trial.
Hurvitz SA; Andre F; Jiang Z; Shao Z; Mano MS; Neciosup SP; Tseng LM; Zhang Q; Shen K; Liu D; Dreosti LM; Burris HA; Toi M; Buyse ME; Cabaribere D; Lindsay MA; Rao S; Pacaud LB; Taran T; Slamon D
Lancet Oncol; 2015 Jul; 16(7):816-29. PubMed ID: 26092818
[TBL] [Abstract][Full Text] [Related]
7. Very early administration of progesterone for acute traumatic brain injury.
Wright DW; Yeatts SD; Silbergleit R; Palesch YY; Hertzberg VS; Frankel M; Goldstein FC; Caveney AF; Howlett-Smith H; Bengelink EM; Manley GT; Merck LH; Janis LS; Barsan WG;
N Engl J Med; 2014 Dec; 371(26):2457-66. PubMed ID: 25493974
[TBL] [Abstract][Full Text] [Related]
8. Magnesium sulfate for neuroprotection after traumatic brain injury: a randomised controlled trial.
Temkin NR; Anderson GD; Winn HR; Ellenbogen RG; Britz GW; Schuster J; Lucas T; Newell DW; Mansfield PN; Machamer JE; Barber J; Dikmen SS
Lancet Neurol; 2007 Jan; 6(1):29-38. PubMed ID: 17166799
[TBL] [Abstract][Full Text] [Related]
9. Anticoagulant therapy for symptomatic calf deep vein thrombosis (CACTUS): a randomised, double-blind, placebo-controlled trial.
Righini M; Galanaud JP; Guenneguez H; Brisot D; Diard A; Faisse P; Barrellier MT; Hamel-Desnos C; Jurus C; Pichot O; Martin M; Mazzolai L; Choquenet C; Accassat S; Robert-Ebadi H; Carrier M; Le Gal G; Mermilllod B; Laroche JP; Bounameaux H; Perrier A; Kahn SR; Quere I
Lancet Haematol; 2016 Dec; 3(12):e556-e562. PubMed ID: 27836513
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of paracetamol for acute low-back pain: a double-blind, randomised controlled trial.
Williams CM; Maher CG; Latimer J; McLachlan AJ; Hancock MJ; Day RO; Lin CW
Lancet; 2014 Nov; 384(9954):1586-96. PubMed ID: 25064594
[TBL] [Abstract][Full Text] [Related]
11. Cost-Effectiveness of Erythropoietin in Traumatic Brain Injury: A Multinational Trial-Based Economic Analysis.
Knott RJ; Harris A; Higgins A; Nichol A; French C; Little L; Haddad S; Presneill J; Arabi Y; Bailey M; Cooper DJ; Duranteau J; Huet O; Mak A; McArthur C; Pettilä V; Skrifvars MB; Vallance S; Varma D; Wills J; Bellomo R
J Neurotrauma; 2019 Sep; 36(17):2541-2548. PubMed ID: 30907230
[TBL] [Abstract][Full Text] [Related]
12. Effect of citicoline on functional and cognitive status among patients with traumatic brain injury: Citicoline Brain Injury Treatment Trial (COBRIT).
Zafonte RD; Bagiella E; Ansel BM; Novack TA; Friedewald WT; Hesdorffer DC; Timmons SD; Jallo J; Eisenberg H; Hart T; Ricker JH; Diaz-Arrastia R; Merchant RE; Temkin NR; Melton S; Dikmen SS
JAMA; 2012 Nov; 308(19):1993-2000. PubMed ID: 23168823
[TBL] [Abstract][Full Text] [Related]
13. Tofacitinib versus etanercept or placebo in moderate-to-severe chronic plaque psoriasis: a phase 3 randomised non-inferiority trial.
Bachelez H; van de Kerkhof PC; Strohal R; Kubanov A; Valenzuela F; Lee JH; Yakusevich V; Chimenti S; Papacharalambous J; Proulx J; Gupta P; Tan H; Tawadrous M; Valdez H; Wolk R;
Lancet; 2015 Aug; 386(9993):552-61. PubMed ID: 26051365
[TBL] [Abstract][Full Text] [Related]
14. Effects of tranexamic acid on death, disability, vascular occlusive events and other morbidities in patients with acute traumatic brain injury (CRASH-3): a randomised, placebo-controlled trial.
CRASH-3 trial collaborators
Lancet; 2019 Nov; 394(10210):1713-1723. PubMed ID: 31623894
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of dexanabinol in severe traumatic brain injury: results of a phase III randomised, placebo-controlled, clinical trial.
Maas AI; Murray G; Henney H; Kassem N; Legrand V; Mangelus M; Muizelaar JP; Stocchetti N; Knoller N;
Lancet Neurol; 2006 Jan; 5(1):38-45. PubMed ID: 16361021
[TBL] [Abstract][Full Text] [Related]
16. Tasimelteon for non-24-hour sleep-wake disorder in totally blind people (SET and RESET): two multicentre, randomised, double-masked, placebo-controlled phase 3 trials.
Lockley SW; Dressman MA; Licamele L; Xiao C; Fisher DM; Flynn-Evans EE; Hull JT; Torres R; Lavedan C; Polymeropoulos MH
Lancet; 2015 Oct; 386(10005):1754-64. PubMed ID: 26466871
[TBL] [Abstract][Full Text] [Related]
17. Antepartum dalteparin versus no antepartum dalteparin for the prevention of pregnancy complications in pregnant women with thrombophilia (TIPPS): a multinational open-label randomised trial.
Rodger MA; Hague WM; Kingdom J; Kahn SR; Karovitch A; Sermer M; Clement AM; Coat S; Chan WS; Said J; Rey E; Robinson S; Khurana R; Demers C; Kovacs MJ; Solymoss S; Hinshaw K; Dwyer J; Smith G; McDonald S; Newstead-Angel J; McLeod A; Khandelwal M; Silver RM; Le Gal G; Greer IA; Keely E; Rosene-Montella K; Walker M; Wells PS;
Lancet; 2014 Nov; 384(9955):1673-83. PubMed ID: 25066248
[TBL] [Abstract][Full Text] [Related]
18. Effects of the bradykinin antagonist Bradycor (deltibant, CP-1027) in severe traumatic brain injury: results of a multi-center, randomized, placebo-controlled trial. American Brain Injury Consortium Study Group.
Marmarou A; Nichols J; Burgess J; Newell D; Troha J; Burnham D; Pitts L
J Neurotrauma; 1999 Jun; 16(6):431-44. PubMed ID: 10391361
[TBL] [Abstract][Full Text] [Related]
19. Safety and efficacy of erythropoietin for the treatment of patients with optic neuritis (TONE): a randomised, double-blind, multicentre, placebo-controlled study.
Lagrèze WA; Küchlin S; Ihorst G; Grotejohann B; Beisse F; Volkmann M; Heinrich SP; Albrecht P; Ungewiss J; Wörner M; Hug MJ; Wolf S; Diem R;
Lancet Neurol; 2021 Dec; 20(12):991-1000. PubMed ID: 34800417
[TBL] [Abstract][Full Text] [Related]
20. Safety and efficacy of desmoteplase given 3-9 h after ischaemic stroke in patients with occlusion or high-grade stenosis in major cerebral arteries (DIAS-3): a double-blind, randomised, placebo-controlled phase 3 trial.
Albers GW; von Kummer R; Truelsen T; Jensen JK; Ravn GM; Grønning BA; Chabriat H; Chang KC; Davalos AE; Ford GA; Grotta J; Kaste M; Schwamm LH; Shuaib A;
Lancet Neurol; 2015 Jun; 14(6):575-84. PubMed ID: 25937443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
